Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Quality Index
Yifan Xinfu Pharmaceutical Co Ltd cash flow quality index. Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow Quality Index of 0.48x as of September 2025. Operating cash flow of CN¥40.18 Million is below net income of CN¥84.14 Million, suggesting accrual-heavy earnings not yet converted to cash. See Yifan Xinfu Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Cash flow quality index of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. Historical Cash Flow Quality Index for Yifan Xinfu Pharmaceutical Co Ltd across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Yifan Xinfu Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2003–2025)
Yifan Xinfu Pharmaceutical Co Ltd cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for Yifan Xinfu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Yifan Xinfu Pharmaceutical Co Ltd (002019) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.14x | CN¥458.37 Million | CN¥402.02 Million | ▼ -42.4% |
| 2024 | 1.98x | CN¥640.73 Million | CN¥323.62 Million | ▼ -19.8% |
| 2022 | 2.47x | CN¥472.07 Million | CN¥191.22 Million | ▲ +98.5% |
| 2021 | 1.24x | CN¥301.23 Million | CN¥242.21 Million | ▲ +4.5% |
| 2020 | 1.19x | CN¥1.11 Billion | CN¥931.39 Million | ▲ +10.9% |
| 2019 | 1.07x | CN¥937.24 Million | CN¥873.12 Million | ▼ -36.4% |
| 2018 | 1.69x | CN¥1.17 Billion | CN¥693.68 Million | ▲ +94.5% |
| 2017 | 0.87x | CN¥1.13 Billion | CN¥1.31 Billion | ▼ -28.5% |
| 2016 | 1.21x | CN¥855.85 Million | CN¥704.76 Million | ▲ +9.4% |
| 2015 | 1.11x | CN¥401.96 Million | CN¥361.96 Million | ▲ +89.1% |
| 2014 | 0.59x | CN¥139.74 Million | CN¥237.94 Million | ▼ -56.2% |
| 2013 | 1.34x | CN¥34.32 Million | CN¥25.61 Million | ▼ -49.2% |
| 2012 | 2.64x | CN¥29.88 Million | CN¥11.32 Million | ▲ +36.8% |
| 2009 | 1.93x | CN¥58.61 Million | CN¥30.37 Million | ▼ -4.5% |
| 2008 | 2.02x | CN¥83.31 Million | CN¥41.24 Million | ▲ +95.1% |
| 2007 | 1.04x | CN¥248.71 Million | CN¥240.19 Million | ▼ -93.8% |
| 2006 | 16.77x | CN¥32.62 Million | CN¥1.94 Million | ▲ +1326.0% |
| 2005 | 1.18x | CN¥24.12 Million | CN¥20.51 Million | ▲ +13.9% |
| 2004 | 1.03x | CN¥33.59 Million | CN¥32.52 Million | ▲ +111.2% |
| 2003 | 0.49x | CN¥12.65 Million | CN¥25.88 Million | — |